Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Additional Listing

1 Apr 2009 07:00

RNS Number : 8789P
Polar Capital Holdings PLC
01 April 2009
Β 

ο»Ώ

1 April 2009

Polar Capital Holdings plcΒ 

Issue of equity

Polar Capital Holdings plc ('Polar Capital' or 'the Company') announces the issueΒ and allotment ofΒ 1,629,589Β ordinary shares of 2.5p each in the CompanyΒ ('the New Shares')Β in respect of the previously announced crystallisation ofΒ theΒ UKΒ business units.Β Application has been made for theΒ NewΒ Shares to be admitted to trading on AIM and dealings are expected to commence onΒ 2Β AprilΒ 2009.

This is theΒ thirdΒ allotment of shares for theΒ UKΒ business unit. AsΒ previously announced there will beΒ oneΒ further trancheΒ of 1,629,589 sharesΒ each toΒ be issued in respect of the crystallisation of the UK business unit, in March 2010.Β On 1 April 2008, the CompanyΒ announced that the two further tranches of shares to be issued in respect of the crystallisation of theΒ UKΒ business unit in March 2009 and March 2010, would comprise 1,682,595 ordinary shares each. However, as a result ofΒ a change ofΒ personnel at the Company, both this year's and next year's tranchesΒ are nowΒ comprised ofΒ 1,629,589Β ordinary shares each.

Β As at 31 MarchΒ 2009, following admission of theΒ NewΒ Shares, the total number of ordinary shares allotted and in issue will be 73,073,568.

BackgroundΒ 

Polar Capital has structured its fund management operations in such a way that the fund management teams are placed in separate business unitsΒ and remunerated directly via performance andΒ alsoΒ given an incentive to become shareholders in theΒ Company.

Each business unit is a separate profit centre and the fund managers responsible receiveΒ an annualΒ payment which comprises a share of their unit's core operatingΒ profit (operating profit before performance fees and related distributions) and performance fees. In addition each fund management team is offered the prospect of an interest in the capital of the Company through the purchase ofΒ anΒ individual class of preference shares in Polar Capital Partners Limited, a wholly owned subsidiary of the Company. These preference shares have been structured in such a way as to become convertible upon the occurrence of certain events know as crystallisation events into cash or, at the option of the Company, ordinary sharesΒ in the CompanyΒ at a ratio that is intended to be earnings enhancing for theΒ Company.

Upon the occurrence of a crystallisation event the fund mangers concerned cease to be eligible to receive their share of the business unit's core operating profit and simultaneously going forward receive a reduced interest in their performance fees.

Enquiries:

Polar Capital Holdings

Neil Taylor

Tel:Β Β +44Β (0)20Β 7227 2711

Numis Securities

Tel: +44 (0)20 7260 1000

Lee Aston (Nominated Adviser)

Charles Farquhar (Corporate Broking)

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
LISMGGFFMMZGLZZ
Date   Source Headline
11th Jul 20247:00 amRNSAuM Update
4th Jul 20246:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20245:05 pmRNSHolding(s) in Company
27th Jun 20241:15 pmRNSGroup Audited Results for year ended 31 March 2024
27th Jun 20247:00 amRNSGroup Audited Results for year ended 31 March 2024
17th Jun 20243:37 pmRNSForm 8.3 - CREST NICHOLSON HOLDINGS
3rd Jun 20246:16 pmRNSTotal Voting Rights
3rd Jun 20241:56 pmRNSTotal Voting Rights
22nd May 20249:12 amRNSIssue of Equity
15th May 202410:06 amRNSDirector/PDMR Shareholding
13th May 20245:49 pmRNSHolding(s) in Company
13th May 20243:34 pmRNSHolding(s) in Company
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.